Process View
The process in which a relatively unspecialized cell acquires specialized structural and/or functional features of an enteroendocrine cell. Enteroendocrine cells are hormonally active epithelial cells in the gut that constitute the diffuse neuroendocrine system.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "enteroendocrine cell differentiation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CDK6 | cyclin-dependent kinase 6 | 0.999 | ||
| MAFA | v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) | 0.998 | ||
| CCND1 | cyclin D1 | 0.998 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.988 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.971 | ||
| CCND3 | cyclin D3 | 0.947 | ||
| TSC2 | tuberous sclerosis 2 | 0.829 | ||
| CDK4 | cyclin-dependent kinase 4 | 0.709 | Human | |
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.583 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.543 | ||
| CLOCK | clock homolog (mouse) | 0.382 | Mouse | |
| NOG | noggin | 0.374 | ||
| ARNTL | aryl hydrocarbon receptor nuclear translocator-like | 0.357 | Mouse | |
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.281 | ||
| NEUROD1 | neurogenic differentiation 1 | 0.260 | Mouse | |
| FSTL1 | follistatin-like 1 | 0.220 | ||
| HNF1A | HNF1 homeobox A | 0.212 | ||
| RB1 | retinoblastoma 1 | 0.140 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.130 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.105 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.097 | ||
| SBF1 | SET binding factor 1 | 0.091 | ||
| CCND2 | cyclin D2 | 0.070 | ||
| CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 0.062 | ||
| CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.053 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.053 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.051 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.045 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.037 | ||
| PDX1 | pancreatic and duodenal homeobox 1 | 0.037 | ||
| CCNE1 | cyclin E1 | 0.037 | ||
| CDK5 | cyclin-dependent kinase 5 | 0.036 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.030 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.030 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.030 | ||
| CDKN2D | cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) | 0.029 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.027 | ||
| CDK11B | cyclin-dependent kinase 11B | 0.026 | ||
| NKX2-2 | NK2 homeobox 2 | 0.026 | Mouse | |
| RUNX1 | runt-related transcription factor 1 | 0.025 | ||
| FOXA2 | forkhead box A2 | 0.022 | ||
| MCM10 | minichromosome maintenance complex component 10 | 0.017 | ||
| AHR | aryl hydrocarbon receptor | 0.013 | ||
| ZNF331 | zinc finger protein 331 | 0.013 | ||
| CDK14 | cyclin-dependent kinase 14 | 0.011 | ||
| NKX6-1 | NK6 homeobox 1 | 0.011 | Zebrafish Rat | |
| DTNBP1 | dystrobrevin binding protein 1 | 0.011 | ||
| ZFYVE26 | zinc finger, FYVE domain containing 26 | 0.011 | ||
| BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | 0.011 | ||
| C1orf93 | chromosome 1 open reading frame 93 | 0.010 | ||
| SNF8 | SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae) | 0.010 | ||
| POU3F4 | POU class 3 homeobox 4 | 0.010 |